Results 101 to 110 of about 1,997 (174)

Case report : treatment of Familial Chylomicronaemia Syndrome with lomitapide

We present the case of a male patient with familial chylomicronaemia syndrome (FCS) and thrombocytopenia treated with lomitapide on compassionate grounds.
Robertson, Louise, Dawson, Charlotte, Ochoa-Ferraro, Antonio, Wanninayake, Subadra, Lorde, Nathan   +4 more
core  

Lomitapide hepatic safety: A long-term retrospective analysis in patients with homozygous familial hypercholesterolaemia

Atherosclerosis Plus, 2023
J. Cegla, D. Larrey, L. D’Erasmo, S. O’Brien, M. Arca   +4 more
doaj   +1 more source

A whole-animal phenotypic drug screen identifies suppressors of atherogenic lipoproteins. [PDF]

Elife
Kelpsch DJ, Zhang L, Thierer JH, Rivera Cruz AG, Koren K, Kumar U, Lin Y, Hensley MR, Sohn M, Liu JO, Lectka T, Mumm JS, Farber SA.   +12 more
europepmc   +1 more source

Lomitapide mesylate and lomitapide target ALDOA to inhibit growth and enhance gemcitabine efficacy in PDAC. [PDF]

iScience
Liu YJ, Zhao FY, Wang JM, Li BQ, Lu SY, Li C, Wang HQ.   +6 more
europepmc   +1 more source

Current and Future Perspectives of LDL-C Lowering Therapies 2026. [PDF]

J Atheroscler Thromb
Tada H, Sakata K, Usui S, Takamura M.
europepmc   +1 more source

The Crimean-Congo haemorrhagic fever virus hijacks the liver lipid metabolic pathway for virion production. [PDF]

Emerg Microbes Infect
Gautam A, Zhong L, Ogire E, Bodoirat S, Riedmiller I, Sander WJ, Boson B, Gandhi A, Burlaud-Gaillard J, Amirache F, Legros V, Roingeard P, Lotteau V, Mathieu C, Cosset FL, Denolly S.   +15 more
europepmc   +1 more source

Lipoprotein apheresis: still needed in many patients, or soon a historical practice? [PDF]

Clin Kidney J
Schettler VJJ, Akgun Y, Floege J, Zoccali C.   +3 more
europepmc   +1 more source

TM9SF1 Aggravates Liver Ischemia-Reperfusion Injury by Promoting Autophagy. [PDF]

Inflammation
Wu T, Li W, Zhu Y, Liu X, Yu H, Li H, Zhang J, Tang H, Ding M, Guo W.   +9 more
europepmc   +1 more source

An Improved Prognosis in Subjects With Homozygous Familial Hypercholesterolemia Associated With Advances in LDL-Lowering Therapy. [PDF]

J Atheroscler Thromb
Tada H, Takamura M.
europepmc   +1 more source

Real-world safety and effectiveness of lomitapide in homozygous familial hypercholesterolaemia over ten years: Data from the Lomitapide Observational Worldwide Evaluation Registry (LOWER)

Atherosclerosis Plus
J. Cegla, Dirk Blom, J. Underberg, Christopher Cannon, Dominique Larrey, Lukas Makris, Inbar Aviezer, Ruth Louzado, S. Löwe, Sallyann O'Brien   +9 more
semanticscholar   +1 more source